The hormone resistin links obesity to diabetes
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is a chronic disease that leads to complications including heart disease, stroke, kidney failure, blindness and nerve damage. Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Here we show that adipocytes secrete a unique signalling molecule, which we have named resistin (for resistance to insulin). Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity. Moreover, treatment of normal mice with recombinant resistin impairs glucose tolerance and insulin action. Insulin-stimulated glucose uptake by adipocytes is enhanced by neutralization of resistin and is reduced by resistin treatment. Resistin is thus a hormone that potentially links obesity to diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, resistin is predominantly secreted by adipose tissue, whereas in humans, it is primarily produced by immune cells, suggesting a potential species-specific functional divergence [9].”
From The Resistin/TLR4/miR-155-5p axis: a novel signaling pathway in the onset of hypothalamic neuroinflammation (2025) · cites this paper as [9]
In the citing paper
“The subcutaneous injection of estradiol benzoate reduces resistin levels in adipocytes [136].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [136]
Citations
Cites
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von Heijne, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,356
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationNakai, K., & Horton, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01336-x · Cited by 2,181 · cited 1×
“A notable feature of the deduced amino-acid sequence of resistin is a hydrophobic amino terminus that is predicted by the Prosor”
BackgroundmPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Cited by
Items 201–300 of 1,052
Menzaghi, C., Ercolino, T., Di Paola, R., Berg, A. H., Warram, J. H., Scherer, P. E., Trischitta, V., & Doria, A. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2306 · Cited by 428
Resistin, central obesity, and type 2 diabetes
McTernan, C., McTernan, P., Harte, A., Levick, P., Barnett, A., & Kumar, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07281-1 · Cited by 423
Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management
Garcia-Compean, D., Jaquez-Quintana, J. O., Gonzalez-Gonzalez, J. A., & Maldonado-Garza, H. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.280 · Cited by 423
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones
ARNER, P. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00024-9 · Cited by 423
Norris, A. W., Chen, L., Fisher, S. J., Szanto, I., Ristow, M., Jozsi, A. C., Hirshman, M. F., Rosen, E. D., Goodyear, L. J., Gonzalez, F. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17305 · Cited by 417
Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease
Caballero, A. E. (2003) · Obesity Research · doi:10.1038/oby.2003.174 · Cited by 416
Shetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S., & Veves, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2450 · Cited by 415
Inflammation, a Link between Obesity and Cardiovascular Disease
Wang, Z., & Nakayama, T. (2010) · Mediators of Inflammation · doi:10.1155/2010/535918 · Cited by 412
PPARγ AND G LUCOSE H OMEOSTASIS
Picard, F., & Auwerx, J. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102808 · Cited by 411
Way, J. M., Görgün, C. Z., Tong, Q., Uysal, K. T., Brown, K. K., Harrington, W. W., Oliver, W. R., Willson, T. M., Kliewer, S. A., & Hotamisligil, G. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100189200 · Cited by 411
Obesity, Inflammation, and Periodontal Disease
Pischon, N., Heng, N., Bernimoulin, J.-P., Kleber, B.-M., Willich, S. N., & Pischon, T. (2007) · Journal of Dental Research · doi:10.1177/154405910708600503 · Cited by 408
Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis
Seldin, M. M., Peterson, J. M., Byerly, M. S., Wei, Z., & Wong, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336834 · Cited by 406
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast
Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H., & Shimomura, I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.210 · Cited by 400
Effect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance
Monzillo, L. U., Hamdy, O., Horton, E. S., Ledbury, S., Mullooly, C., Jarema, C., Porter, S., Ovalle, K., Moussa, A., & Mantzoros, C. S. (2003) · Obesity Research · doi:10.1038/oby.2003.144 · Cited by 397
IL-17 regulates adipogenesis, glucose homeostasis, and obesity
Zúñiga, L. A., Shen, W.-J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M., Cua, D. J., Kraemer, F. B., & Butcher, E. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001269 · Cited by 394
Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
Petersen, K. F., & Shulman, G. I. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02554-7 · Cited by 392
Adipose tissue and adipokines: for better or worse
Guerre-Millo, M. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70084-8 · Cited by 387
Association of Adiponectin Mutation With Type 2 Diabetes
Kondo, H., Shimomura, I., Matsukawa, Y., Kumada, M., Takahashi, M., Matsuda, M., Ouchi, N., Kihara, S., Kawamoto, T., Sumitsuji, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2325 · Cited by 385
AMPK inhibition in health and disease
Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., & Andreelli, F. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.488215 · Cited by 383
Nagaev, I., & Smith, U. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5173 · Cited by 380
The role of adipokines in chronic inflammation
Mancuso, P. (2016) · ImmunoTargets and Therapy · doi:10.2147/itt.s73223 · Cited by 378
Intermittent Hypoxia Increases Insulin Resistance in Genetically Obese Mice
Polotsky, V. Y., Li, J., Punjabi, N. M., Rubin, A. E., Smith, P. L., Schwartz, A. R., & O'Donnell, C. P. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.048173 · Cited by 376
Jensen, T., Kiersgaard, M., Sørensen, D., & Mikkelsen, L. (2013) · Laboratory Animals · doi:10.1177/0023677213501659 · Cited by 373
The current biology of resistin
Steppan, C. M., & Lazar, M. A. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01306.x · Cited by 373
Self-citationHormonal regulation of food intake
Stanley, S., Wynne, K., McGowan, B., & Bloom, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00015.2004 · Cited by 372
Role of resistin in diet-induced hepatic insulin resistance
Muse, E. D., Obici, S., Bhanot, S., Monia, B. P., McKay, R. A., Rajala, M. W., Scherer, P. E., & Rossetti, L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421270 · Cited by 372
Association of the T-G Polymorphism in Adiponectin (Exon 2) With Obesity and Insulin Sensitivity
Stumvoll, M., Tschritter, O., Fritsche, A., Staiger, H., Renn, W., Weisser, M., Machicao, F., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.1.37 · Cited by 371
“Thus, in contrast to previously discussed peptide hormones released from adipocytes (tumor necrosis factor- (7,8) and resistin (9), adiponectin seems to protect from insulin resistance and type 2 diabetes.”
ResultCorrelation between Serum Resistin Level and Adiposity in Obese Individuals
Azuma, K., Katsukawa, F., Oguchi, S., Murata, M., Yamazaki, H., Shimada, A., & Saruta, T. (2003) · Obesity Research · doi:10.1038/oby.2003.137 · Cited by 370
The emerging role of adipokines as mediators of inflammation and immune responses
Lago, F., Dieguez, C., Gómez-Reino, J., & Gualillo, O. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.04.007 · Cited by 370
The Role of TNF-α in Insulin Resistance
Borst, S. E. (2004) · Endocrine · doi:10.1385/endo:23:2-3:177 · Cited by 369
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Dongiovanni, P., Fracanzani, A. L., Fargion, S., & Valenti, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.008 · Cited by 362
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony
Herman, M. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29027 · Cited by 355
Adipogenesis: forces that tip the scales
MacDougald, O. A., & Mandrup, S. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00517-3 · Cited by 355
Adiponectin, the missing link in insulin resistance and obesity
GILCAMPOS, M. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.04.010 · Cited by 353
Retinol-Binding Protein 4 in Human Obesity
Janke, J., Engeli, S., Boschmann, M., Adams, F., Böhnke, J., Luft, F. C., Sharma, A. M., & Jordan, J. (2006) · Diabetes · doi:10.2337/db06-0616 · Cited by 352
Balagopal, P. (., de Ferranti, S. D., Cook, S., Daniels, S. R., Gidding, S. S., Hayman, L. L., McCrindle, B. W., Mietus-Snyder, M. L., & Steinberger, J. (2011) · Circulation · doi:10.1161/cir.0b013e31821c7c64 · Cited by 352
Regulation of Resistin Expression and Circulating Levels in Obesity, Diabetes, and Fasting
Rajala, M. W., Qi, Y., Patel, H. R., Takahashi, N., Banerjee, R., Pajvani, U. B., Sinha, M. K., Gingerich, R. L., Scherer, P. E., & Ahima, R. S. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1671 · Cited by 351
Self-citationImpact of obesity on infertility in women
Ozcan Dag, Z., & Dilbaz, B. (2015) · Journal of the Turkish German Gynecological Association · doi:10.5152/jtgga.2015.15232 · Cited by 351
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance
Asakawa, A., Inui, A., Yuzuriha, H., Ueno, N., Katsuura, G., Fujimiya, M., Fujino, M. A., Niijima, A., Meguid, M. M., & Kasuga, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00216-6 · Cited by 350
Nonalcoholic fatty liver disease: A review of current understanding and future impact
Charlton, M. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00440-9 · Cited by 350
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Adipokines in nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2015.11.006 · Cited by 348
Zimmermann, U., Kraus, T., Himmerich, H., Schuld, A., & Pollmächer, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00018-9 · Cited by 347
Obesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345
Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective
Arnardottir, E. S., Mackiewicz, M., Gislason, T., Teff, K. L., & Pack, A. I. (2009) · Sleep · doi:10.1093/sleep/32.4.447 · Cited by 345
Mechanisms of thrombosis in obesity
Blokhin, I. O., & Lentz, S. R. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283634443 · Cited by 345
Parker, B., Noakes, M., Luscombe, N., & Clifton, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.425 · Cited by 340
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340
Endocrine Functions of Adipose Tissue
Waki, H., & Tontonoz, P. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091859 · Cited by 338
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Non-alcoholic fatty liver disease and the metabolic syndrome: An update
Rector, R. S., Thyfault, J. P., Wei, Y., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.185 · Cited by 332
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stumvoll, M., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 332
Calabro, P., Samudio, I., Willerson, J. T., & Yeh, E. T. H. (2004) · Circulation · doi:10.1161/01.cir.0000147825.97879.e7 · Cited by 331
The complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
Adipose tissue, obesity and adipokines: role in cancer promotion
Booth, A., Magnuson, A., Fouts, J., & Foster, M. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0037 · Cited by 329
Sarjeant, K., & Stephens, J. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008417 · Cited by 328
“Immunoneutralization studies suggested that this hormone, resistin, might be involved in the pathogenesis of insulin resistance (Steppan et al. 2001).”
Kabir, M., Catalano, K. J., Ananthnarayan, S., Kim, S. P., Van Citters, G. W., Dea, M. K., & Bergman, R. N. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00203.2004 · Cited by 327
Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice
Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S., Ishihara, A., Kanatani, A., Itadani, H., & Kotani, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309895200 · Cited by 327
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Metabolic effects of obesity: A review
Singla, P. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i3.76 · Cited by 326
Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505649200 · Cited by 326
Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue
Yu, Y.-H., & Ginsberg, H. N. (2005) · Circulation Research · doi:10.1161/01.res.0000165803.47776.38 · Cited by 326
Choi, C. S., Savage, D. B., Abu-Elheiga, L., Liu, Z.-X., Kim, S., Kulkarni, A., Distefano, A., Hwang, Y.-J., Reznick, R. M., Codella, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706794104 · Cited by 325
Stojsavljević, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18070 · Cited by 325
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., & Liew, F. Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.218867 · Cited by 324
Depletion of fat-resident Treg cells prevents age-associated insulin resistance
Bapat, S. P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., Zhou, C., Liang, Y., LeBlanc, M., Liddle, C., et al. (2015) · Nature · doi:10.1038/nature16151 · Cited by 324
Chemistry and Biochemistry of Type 2 Diabetes
Ross, S. A., Gulve, E. A., & Wang, M. (2004) · Chemical Reviews · doi:10.1021/cr0204653 · Cited by 323
Metabolic disturbances connecting obesity and depression
Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322
Loke, P., Nair, M. G., Parkinson, J., Guiliano, D., Blaxter, M., & Allen, J. E. (2002) · BMC Immunology · doi:10.1186/1471-2172-3-7 · Cited by 322
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K., Nestler, J. E., Sattar, N., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 322
Michalakis, K., Mintziori, G., Kaprara, A., Tarlatzis, B. C., & Goulis, D. G. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.012 · Cited by 321
“Resistin is a dimeric protein that owes its name to its suggested role as an insulinresistance mediator [161].”
BackgroundResistin Gene Expression in Human Adipocytes Is Not Related to Insulin Resistance
Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., & Sharma, A. M. (2002) · Obesity Research · doi:10.1038/oby.2002.1 · Cited by 319
Molecular mechanisms of insulin resistance
Schinner, S., Scherbaum, W. A., Bornstein, S. R., & Barthel, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01566.x · Cited by 319
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
“Mouse resistin is expressed and secreted predominantly by white adipocytes (Steppan et al., 2001), whereas a scan of a variety of human tissues showed that human resistin is expressed at the highest level in macrophages in bone marrow followed by lung, with almost undetectable levels in adipocytes…”
BackgroundKao, Y., Chang, H., Lee, M., & Chen, C. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500109 · Cited by 318
Adipokines and the Peripheral and Neural Control of Energy Balance
Ahima, R. S., & Lazar, M. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0529 · Cited by 315
Self-citationThe impact of aging on adipose function and adipokine synthesis
Mancuso, P., & Bouchard, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00137 · Cited by 314
Ando, H., Yanagihara, H., Hayashi, Y., Obi, Y., Tsuruoka, S., Takamura, T., Kaneko, S., & Fujimura, A. (2005) · Endocrinology · doi:10.1210/en.2005-0771 · Cited by 312
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Chen, H., Tan, H., Wan, J., Zeng, Y., Wang, J., Wang, H., & Lu, X. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108391 · Cited by 311
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309
Bing, C., Bao, Y., Jenkins, J., Sanders, P., Manieri, M., Cinti, S., Tisdale, M. J., & Trayhurn, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308647100 · Cited by 309
Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes
Yamauchi, T., Waki, H., Kamon, J., Murakami, K., Motojima, K., Komeda, K., Miki, H., Kubota, N., Terauchi, Y., Tsuchida, A., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12864 · Cited by 308
Heilbronn, L. K., Rood, J., Janderova, L., Albu, J. B., Kelley, D. E., Ravussin, E., & Smith, S. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031410 · Cited by 307
Disulfide-Dependent Multimeric Assembly of Resistin Family Hormones
Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E., & Shapiro, L. (2004) · Science · doi:10.1126/science.1093466 · Cited by 307
Pathophysiological implications of insulin resistance on vascular endothelial function
Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 306
Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease
Karmiris, K., Koutroubakis, I. E., Xidakis, C., Polychronaki, M., Voudouri, T., & Kouroumalis, E. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000200345.38837.46 · Cited by 305
Retinoid X receptors: X-ploring their (patho)physiological functions
Szanto, A., Narkar, V, Shen, Q., Uray, I. P., Davies, P. J. A., & Nagy, L. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401533 · Cited by 302
Polycystic ovary syndrome: Syndrome XX?
Sam, S., & Dunaif, A. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.002 · Cited by 302
Molecular mechanisms of insulin resistance and associated diseases
Mlinar, B., Marc, J., Janež, A., & Pfeifer, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.005 · Cited by 301
Adipose tissue as an endocrine organ: from theory to practice
Fonseca-Alaniz, M. H., Takada, J., Alonso-Vale, M. I. C., & Lima, F. B. (2007) · Jornal de Pediatria · doi:10.2223/jped.1709 · Cited by 299
Maurovich-Horvat, P., Massaro, J., Fox, C. S., Moselewski, F., O'Donnell, C. J., & Hoffmann, U. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803454 · Cited by 298
Human resistin: found in translation from mouse to man
Schwartz, D. R., & Lazar, M. A. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.03.005 · Cited by 297
Self-citationObesity in Dogs and Cats: A Metabolic and Endocrine Disorder
Zoran, D. L. (2010) · Veterinary Clinics of North America: Small Animal Practice · doi:10.1016/j.cvsm.2009.10.009 · Cited by 297
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
Guan, Y., & Breyer, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00766.x · Cited by 295
Muise, E. S., Azzolina, B., Kuo, D. W., El-Sherbeini, M., Tan, Y., Yuan, X., Mu, J., Thompson, J. R., Berger, J. P., & Wong, K. K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.044826 · Cited by 294
Systemic Oxidative Stress is Associated With Visceral Fat Accumulation and the Metabolic Syndrome
Fujita, K., Nishizawa, H., Funahashi, T., Shimomura, I., & Shimabukuro, M. (2006) · Circulation Journal · doi:10.1253/circj.70.1437 · Cited by 293
Insulin resistance: a phosphorylation-based uncoupling of insulin signaling
Zick, Y. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02129-8 · Cited by 292
Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet
Burcelin, R., Crivelli, V., Dacosta, A., Roy-Tirelli, A., & Thorens, B. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00332.2001 · Cited by 292
Role of adipokines in cardiovascular disease
Mattu, H. S., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0232 · Cited by 292
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 291
Metadata
- Authors
- Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A.
- Affiliations
- University of Pennsylvania Health System (US)
- University of Pennsylvania (US)
- Corresponding author
- Lazar, Mitchell A.
- Venue
- Nature
- Published
- 2001-01
- Volume
- 409
- Issue
- 6818
- Pages
- 307-312
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1675830194
- Cited by
- 4,755
- References
- 37
- Citations by year
- 2026: 59 · 2025: 77 · 2024: 108 · 2023: 128 · 2022: 152 · 2021: 147 · 2020: 140 · 2019: 160 · 2018: 137 · 2017: 187 · 2016: 175 · 2015: 197 · 2014: 239 · 2013: 243 · 2012: 217
- FWCI
- 184.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- resistin, obesity, type 2 diabetes, insulin resistance, adipocytes, adipokines, rosiglitazone, glucose tolerance, insulin-stimulated glucose uptake, diet-induced obesity, genetic obesity
- MeSH terms
- Rosiglitazone, Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 19, Cloning, Molecular, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diet, DNA, Female, Gene Expression Regulation, Hormones, Hormones, Ectopic, Humans, Hypoglycemic Agents, Insulin Antagonists, Insulin Resistance, Male, Mice, Inbred C57BL, Molecular Sequence Data, Neutralization Tests, Obesity, Proteins, Thiazoles, Signal Transduction, 3T3 Cells, Adipocytes, Glucose Intolerance, Nerve Growth Factor, Intercellular Signaling Peptides and Proteins, Thiazolidinediones, Mice, Resistin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.